C4 THERAPEUTICS INC (CCCC) Stock Analyst Earnings Estimates
NASDAQ:CCCC - Nasdaq - US12529R1077 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.79M 37.92% | 31.1M -32.08% | 20.756M -33.26% | 36.486M 75.79% | 16.949M -53.55% | 18.093M 6.75% | 20.706M 14.44% | 150.01M 624.48% | 1.309B 772.61% | 4.534B 246.37% | 341.96M -92.46% | 472.96M 38.31% | |
| EBITDA YoY % growth | -80.64M -37.07% | -127.85M -58.54% | -137.151M -7.27% | -100.444M 26.76% | -148.809M -48.15% | -167.952M -12.86% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -82.13M -35.86% | -129.53M -57.71% | -139.031M -7.33% | -118.343M 14.88% | -131.811M -11.38% | -165.529M -25.58% | -205.465M -24.13% | -121.804M 40.72% | 336.79M 376.50% | 1.958B 481.37% | -15.596M -100.80% | 107.4M 788.65% | |
| Operating Margin | -179.36% | -416.50% | -669.84% | -324.35% | -777.69% | -914.88% | -992.30% | -81.20% | 25.73% | 43.18% | -4.56% | 22.71% | |
| EPS YoY % growth | -1.82 83.87% | -2.63 -44.51% | -2.66 -1.14% | -1.56 41.52% | -1.85 -19.18% | -1.85 0.41% | -1.55 16.02% | 0.95 161.51% | 14.39 1,409.09% | 42.60 196.00% | 1.80 -95.79% | 2.63 46.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.47 33.15% | -0.42 -3.49% | -0.42 -60.85% | -0.47 -34.06% | -0.45 4.09% |
| Revenue Q2Q % growth | 5.246M 60.87% | 3.4M 11.88% | 3.4M -71.68% | 3.4M -77.87% | 3.4M -35.19% |
| EBITDA Q2Q % growth | -37.74M -6.17% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -39.561M -5.70% | -36.537M -22.68% | -37.101M -73.03% | -43.787M -55.03% | -44.308M -12.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.35 32.69% | -0.39 | 0.04 | 9.70% |
| Q2 2024 Q2Q % growth | -0.26 64.38% | -0.38 | 0.12 | 31.42% |
| Q1 2024 Q2Q % growth | -0.41 42.25% | -0.36 | -0.05 | -14.38% |
| Q4 2023 Q2Q % growth | -0.70 9.09% | -0.70 | 0.00 | -0.55% |
| Q3 2023 Q2Q % growth | -0.52 20.00% | -0.67 | 0.15 | 22.76% |
| Q2 2023 Q2Q % growth | -0.73 -30.36% | -0.70 | -0.03 | -4.06% |
| Q1 2023 Q2Q % growth | -0.71 -9.23% | -0.76 | 0.05 | 6.66% |
| Q4 2022 Q2Q % growth | -0.77 -148.39% | -0.76 | -0.01 | -1.50% |
| Q3 2022 Q2Q % growth | -0.65 -27.45% | -0.68 | 0.03 | 4.89% |
| Q2 2022 Q2Q % growth | -0.56 -9.80% | -0.71 | 0.15 | 20.76% |
| Q1 2022 Q2Q % growth | -0.65 -32.65% | -0.59 | -0.06 | -10.14% |
| Q4 2021 Q2Q % growth | -0.31 -675.00% | -0.59 | 0.28 | 47.82% |
| Q3 2021 Q2Q % growth | -0.51 97.09% | -0.60 | 0.09 | 15.49% |
| Q2 2021 Q2Q % growth | -0.51 | -0.60 | 0.09 | 15.25% |
| Q1 2021 Q2Q % growth | -0.49 | -0.64 | 0.15 | 23.75% |
| Q4 2020 Q2Q % growth | -0.04 | -0.54 | 0.50 | 92.60% |
| Q3 2020 Q2Q % growth | -17.55 | -0.81 | -16.74 | -2,077.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 15.362M 38.75% | 4.692M | 10.67M | 227.41% |
| Q2 2024 Q2Q % growth | 12.006M 350.68% | 4.879M | 7.127M | 146.08% |
| Q1 2024 Q2Q % growth | 3.039M -19.15% | 8.262M | -5.223M | -63.22% |
| Q4 2023 Q2Q % growth | 3.261M 14.42% | 3.253M | 8K | 0.25% |
| Q3 2023 Q2Q % growth | 11.072M 64.03% | 5.569M | 5.503M | 98.81% |
| Q2 2023 Q2Q % growth | 2.664M -80.74% | 6.568M | -3.904M | -59.44% |
| Q1 2023 Q2Q % growth | 3.759M -50.86% | 5.572M | -1.813M | -32.54% |
| Q4 2022 Q2Q % growth | 2.85M -85.81% | 7.969M | -5.119M | -64.24% |
| Q3 2022 Q2Q % growth | 6.75M -20.59% | 9.253M | -2.503M | -27.05% |
| Q2 2022 Q2Q % growth | 13.83M 41.41% | 7.79M | 6.04M | 77.54% |
| Q1 2022 Q2Q % growth | 7.65M 2.96% | 8.211M | -561K | -6.83% |
| Q4 2021 Q2Q % growth | 20.08M 143.10% | 7.226M | 12.854M | 177.89% |
| Q3 2021 Q2Q % growth | 8.5M 0.59% | 7.759M | 741K | 9.55% |
| Q2 2021 Q2Q % growth | 9.78M -40.68% | 6.137M | 3.643M | 59.36% |
| Q1 2021 Q2Q % growth | 7.43M | 3.942M | 3.488M | 88.48% |
| Q4 2020 Q2Q % growth | 8.26M -61.37% | 8.16M | 100K | 1.23% |
| Q3 2020 Q2Q % growth | 8.45M | 5.202M | 3.248M | 62.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.94% | -9.23% | -0.42% | -3.64% |
| Revenue | -3.57% | 0.46% | 0% | 25.83% |